Amyloid-β Deposition and Long-Term Progression in Mild Cognitive Impairment due to Alzheimer’s Disease Defined with Amyloid PET Imaging

Albert, 2011, The diagnosis of mild cognitive impairment due to Alzheimer’s disease: Recommendation from the National Institute on Aging-Alzheimer’s Association workgroups on diagnostic guidelines for Alzheimer’s disease, Alzheimers Dement, 7, 270, 10.1016/j.jalz.2011.03.008

Hatashita, 2013, Diagnosed mild cognitive impairment due to Alzheimer’s disease with PET biomarkers of beta amyloid and neuronal dysfunction, PLoS One, 14, e66877, 10.1371/journal.pone.0066877

Klunk, 2004, Langstrom B. Imaging brain amyloid in Alzheimer’ disease with Pittsburgh Compound-B, Ann Neurol, 55, 306, 10.1002/ana.20009

Hatashita, 2010, Clinically different stages of Alzheimer’s disease associated by amyloid deposition with [11C]-PIB PET imaging, J Alzheimers Dis, 21, 995, 10.3233/JAD-2010-100222

Okello, 2009, Conversion of amyloid positive and negative MCI to AD over 3 years: An [11C]-PIB PET study, Neurology, 73, 754, 10.1212/WNL.0b013e3181b23564

Villemagne, 2013, Amyloid B deposition, neurodegeneration, and cognitive decline in sporadic Alzheimer’s disease: A prospective cohort study, Lancet Neurol, 12, 357, 10.1016/S1474-4422(13)70044-9

Jack, 2013, Brain beta-amyloid load approaches a plateau, Neurology, 80, 890, 10.1212/WNL.0b013e3182840bbe

Folstein, 1975, ‘Mini-mental state’ A practical method for grading the cognitive state of patients for the clinician, J Psychiatr Res, 12, 189, 10.1016/0022-3956(75)90026-6

Morris, 1993, The clinical dementia rating (CDR): Current version and scoring rules, Neurology, 43, 2412, 10.1212/WNL.43.11.2412-a

Wechsler, 1987, Wechsler Memory Scale-Revised

Mckhann, 1984, Clinical diagnosis of Alzheimer’s disease-report of the NINCDS-ADRDA work group under the auspices of Department of Health and Human Services Task Force on Alzheimer’s disease, Neurology, 34, 939, 10.1212/WNL.34.7.939

Hatashita, 2014, [11C] Flutemetamol amyloid-beta PET imaging compared with [11C] PIB across the spectrum of Alzheimer’s disease, Eur J Nucl Med Mol Imaging, 41, 290, 10.1007/s00259-013-2564-y

Kemppainen, 2014, Five-year follow-up of 11C-PIB uptake in Alzheimer’s disease and MCI, Eur J Nucl Med Mol Imaging, 41, 283, 10.1007/s00259-013-2562-0

Villain, 2012, Regional dynamics of amyloid-beta deposition in healthy elder, mild cognitive impairment and Alzheimer’s disease: A voxelwise PIB-PET longitudinal study, Brain, 135, 2126, 10.1093/brain/aws125

Jack, 2013, Tracking pathophysiological process in Alzheimer’s disease: An uptake hypothetical model of dynamic biomarkers, Lancet Neurol, 12, 207, 10.1016/S1474-4422(12)70291-0

Lim, 2014, Aβ and cognitive change: Examining the preclinical and prodromal stages of Alzheimer’s disease, Alzheimers Dement, 10, 743, 10.1016/j.jalz.2013.11.005